A business in context

AHCO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4/A · Ownership change

    Report date 2026-08-06 · 0001104659-26-097053

  2. 4 · Ownership change

    Report date 2026-08-06 · 0001104659-26-093576

  3. 4 · Ownership change

    Report date 2026-08-06 · 0001104659-26-093575

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-052646

  5. 8-K · Current report

    Report date 2026-08-04 · 0001628280-26-052149 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-19 · 0001104659-26-085086 · Items 1.01,9.01

  7. 8-K · Current report

    Report date 2026-07-06 · 0001104659-26-081305 · Items 7.01

  8. 4 · Ownership change

    Report date 2026-07-01 · 0001104659-26-080730

  9. 8-K · Current report

    Report date 2026-06-27 · 0001104659-26-080297 · Items 1.05

  10. 4 · Ownership change

    Report date 2026-06-24 · 0001104659-26-078285

  11. 4 · Ownership change

    Report date 2026-06-24 · 0001104659-26-078281

  12. 4 · Ownership change

    Report date 2026-06-24 · 0001104659-26-078268

  13. 4 · Ownership change

    Report date 2026-06-24 · 0001104659-26-078264

  14. 8-K · Current report

    Report date 2026-06-18 · 0001104659-26-076390 · Items 5.07

  15. 8-K/A · Current report

    Report date 2026-05-04 · 0001104659-26-069119 · Items 5.02,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-030602

  17. 8-K · Current report

    Report date 2026-05-05 · 0001628280-26-030120 · Items 2.02,5.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001628280-26-027965

  19. 8-K · Current report

    Report date 2026-04-10 · 0001628280-26-024835 · Items 1.01,1.02,2.03,7.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-011213

  21. 8-K · Current report

    Report date 2026-02-24 · 0001628280-26-010872 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-048944

  23. 8-K · Current report

    Report date 2025-11-04 · 0001628280-25-048527 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-037931

  25. 8-K · Current report

    Report date 2025-08-05 · 0001628280-25-037598 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-08-05 · 0001104659-25-073912 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-06-30 · 0001104659-25-064140 · Items 7.01,9.01

  28. 10-K/A · Annual report

    Report date 2024-12-31 · 0001628280-25-032464

  29. 8-K · Current report

    Report date 2025-06-18 · 0001104659-25-061172 · Items 5.07

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-022716

  31. 8-K · Current report

    Report date 2025-05-06 · 0001628280-25-022394 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-06-18 · 0001628280-25-020890

  33. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-007740

  34. 8-K · Current report

    Report date 2025-02-25 · 0001628280-25-007553 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2024-12-09 · 0001104659-24-128292 · Items 5.02,9.01

  36. SC 13G/A · Ownership disclosure

    0001193805-24-001363

  37. SC 13G · Ownership disclosure

    0001140361-24-046593

  38. SC 13G/A · Ownership disclosure

    0000932471-24-000882

  39. SC 13G/A · Ownership disclosure

    0002012383-24-003746

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-045365

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 10 transaction rows10AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-24
2026-06-26
Williams David Solomon IIIA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
Weaver Susan TA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
Connors Terence JA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
BELINFANTI GREGORYA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
Coppens Bradley JA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
Lundberg Theodore B.A · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
WOLF DALE BA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-24
2026-06-26
SAMET KENNETH AA · Grant / award
Acquired
Common Stock6070.09.89
2026-06-24
2026-06-26
SAMET KENNETH AA · Grant / award
Acquired
Common Stock18999.00.0
2026-06-01
2026-06-03
Schuster III Russell E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11275.010.06
2026-05-27
2026-05-29
McFadden Daniel EdwardA · Grant / award
Acquired
Common Stock20134.00.0
2026-03-13
2026-04-28 · Amendment
Prast Albert A.F · Tax / exercise payment
Disposed
Common Stock58203.010.33

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001725255AdaptHealth Corp.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • DFB Healthcare Acquisitions Corp. · former SEC name · 2017-12-29 to 2019-11-08

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.26B$3.47B
2023-12-31$3.20B$3.51B
2022-12-31$2.97B$3.39B
2021-12-31$2.45B$3.02B
2020-12-31$1.06B$1.36B
2019-12-31$529.64M$691.73M
2018-12-31$345.28M$459.13M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗